Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial

por Bodewes, Iris L A, Gottenberg, Jacques-Eric, van Helden-Meeuwsen, Cornelia G, Mariette, Xavier, Versnel, Marjan A
Publicado 2020

Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren’s Syndrome

por Flessa, Christina-Maria, Zampeli, Evangelia, Evangelopoulos, Maria-Eleftheria, Natsis, Vasilis, Bodewes, Iris L. A., Huijser, Erika, Versnel, Marjan A., Moutsopoulos, Haralampos M., Mavragani, Clio P.
Publicado 2022

Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine

por Collins, Alexis, Lendrem, Dennis, Wason, James, Tarn, Jessica, Howard-Tripp, Nadia, Bodewes, Iris, Versnel, Marjan A., Gottenberg, Jacques-Eric, Seror, Raphaele, Mariette, Xavier, Ng, Wan-Fai
Publicado 2021

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?

por Wahadat, M. Javad, Bodewes, Iris L. A., Maria, Naomi I., van Helden-Meeuwsen, Cornelia G., van Dijk-Hummelman, Annette, Steenwijk, Eline C., Kamphuis, Sylvia, Versnel, Marjan A.
Publicado 2018

Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets

por Bodewes, Iris L. A., van der Spek, Peter J., Leon, Leticia G., Wijkhuijs, Annemarie J. M., van Helden-Meeuwsen, Cornelia G., Tas, Liselotte, Schreurs, Marco W. J., van Daele, Paul L. A., Katsikis, Peter D., Versnel, Marjan A.
Publicado 2019

Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren’s syndrome

por Huijser, Erika, Bodewes, Iris L A, Lourens, Mirthe S, van Helden-Meeuwsen, Cornelia G, van den Bosch, Thierry P P, Grashof, Dwin G B, van de Werken, Harmen J G, Lopes, Ana P, van Roon, Joel A G, van Daele, Paul L A, Brkic, Zana, Dik, Willem A, Versnel, Marjan A
Publicado 2022